Iradimed Corp. (IRMD) Tops Q3 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- Trump threatens to bomb Oman over Iran stance
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
IRADIMED CORPORATION Announces Third Quarter 2016 Financial Results
October 28, 2016 7:00 AM EDTReports third quarter revenue of $7.7 millionReports third quarter GAAP diluted earnings per share of $0.13 and non-GAAP of $0.14
WINTER SPRINGS, Fla., Oct. 28, 2016 (GLOBE NEWSWIRE) -- IRADIMED CORPORATIONÂ (NASDAQ: IRMD), the only known provider of non-magnetic intravenous (IV) infusion pump systems that are designed to be safe for use during magnetic resonance imaging (MRI) procedures, today announced financial results for the three and nine months ended September 30, 2016.Â
For the third quarter ended September 30, 2016, the Company reported revenue of $7.7 million compared to $8.2 million for the third quarter 2015. Revenue for the third quarters ended September 30, 2016 and... More
